Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -20.71% vs 15.09% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -37.20% vs 48.74% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -36.06% vs 49.79% in Sep 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025
Compare Quarterly Results Of OPC Pharmaceutical JSC With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -20.71% vs 15.09% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 2.75% vs -4.83% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -37.20% vs 48.74% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -14.99% vs -28.22% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -36.06% vs 49.79% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -17.60% vs -27.60% in Mar 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






